Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology

被引:27
|
作者
Zehbe, Ingeborg [1 ,2 ,3 ]
Jackson, Robert [1 ,4 ]
Wood, Brianne [5 ]
Weaver, Bruce [3 ]
Escott, Nicholas [3 ,6 ]
Severini, Alberto [7 ]
Krajden, Mel [8 ]
Bishop, Lisa [2 ]
Morrisseau, Kyla [2 ]
Ogilvie, Gina [8 ,9 ]
Burchell, Ann N. [10 ,11 ]
Little, Julian [5 ]
机构
[1] Thunder Bay Reg Res Inst, Probe Dev & Biomarker Explorat, Thunder Bay, ON, Canada
[2] Lakehead Univ, Dept Biol, Thunder Bay, ON, Canada
[3] Northern Ontario Sch Med, Clin Sci, Thunder Bay, ON, Canada
[4] Lakehead Univ, Biotechnol Program, Thunder Bay, ON, Canada
[5] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada
[6] Thunder Bay Reg Hlth Sci Ctr, Dept Pathol & Lab Med, Thunder Bay, ON, Canada
[7] Publ Hlth Agcy Canada, Viral Exanthemata & STD Sect, Natl Microbiol Lab, Winnipeg, MB, Canada
[8] BC Ctr Dis Control, Vancouver, BC, Canada
[9] Univ British Columbia, Sch Populat & Publ Hlth, Fac Med, Vancouver, BC, Canada
[10] Ontario HIV Treatment Network, Toronto, ON, Canada
[11] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
来源
BMJ OPEN | 2016年 / 6卷 / 10期
基金
加拿大健康研究院;
关键词
TO-TREAT ANALYSIS; 1ST NATIONS; NEW-ZEALAND; WOMEN; HPV; STATEMENT; CANADA; INTERVENTION; INDIVIDUALS; AUSTRALIA;
D O I
10.1136/bmjopen-2016-011754
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The incidence of cervical cancer is up to 20-fold higher among First Nations women in Canada than the general population, probably due to lower participation in screening. Offering human papillomavirus (HPV) self-sampling in place of Papanicolaou (Pap) testing may eventually increase screening participation and reduce cervical cancer rates in this population. Design: A community-randomised controlled screening trial. Setting: First Nations communities in Northwest Ontario, Canada. Participants: Women aged between 25 and 69, living in Robinson Superior Treaty First Nations. The community was the unit of randomisation. Interventions: Women were asked to complete a questionnaire and have screening by HPV self-sampling (arm A) or Pap testing (arm B). Primary outcome measures: The number of women who participated in cervical screening. Randomisation: Community clusters were randomised to include approximately equivalent numbers of women in each arm. Results: 6 communities were randomised to arm A and 5 to arm B. One community withdrew, leaving 5 communities in each group (834 eligible women). Participation was <25%. Using clustered intention-to-treat (ITT) analysis, initial and cumulative averaged uptakes in arm A were 1.4-fold (20% vs 14.3%, p=0.628) and 1.3-fold (20.6% vs 16%, p=0.694) higher compared to arm B, respectively. Corresponding per protocol (PP) analysis indicates 2.2-fold (22.9% vs 10.6%, p=0.305) and 1.6-fold (22.9% vs 14.1%, p=0.448) higher uptakes in arm A compared to arm B. Screening uptake varied between communities (range 0-62.1%). Among women who completed a questionnaire (18.3% in arm A, 21.7% in arm B), the screening uptake was 1.8-fold (ITT; p=0.1132) or 3-fold (PP; p<0.01) higher in arm A versus arm B. Conclusions: Pap and HPV self-sampling were compared in a marginalised, Canadian population. Results indicated a preference for self-sampling. More research on how to reach underscreened Indigenous women is necessary.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Determinants for Participation in Human Papillomavirus Self-Sampling among Nonattenders to Cervical Cancer Screening in Denmark
    Harder, Elise
    Thomsen, Louise T.
    Hertzum-Larsen, Rasmus
    Albieri, Vanna
    Hessner, Marie Vik
    Juul, Kirsten Egebjerg
    Bonde, Jesper
    Frederiksen, Kirsten
    Kjaer, Susanne K.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (11) : 1342 - 1351
  • [22] HPV self-sampling as an alternative strategy in non-attenders for cervical screening – a randomised controlled trial
    A Szarewski
    L Cadman
    D Mesher
    J Austin
    L Ashdown-Barr
    R Edwards
    D Lyons
    J Walker
    J Christison
    A Frater
    J Waller
    British Journal of Cancer, 2011, 104 : 915 - 920
  • [23] HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial
    Szarewski, A.
    Cadman, L.
    Mesher, D.
    Austin, J.
    Ashdown-Barr, L.
    Edwards, R.
    Lyons, D.
    Walker, J.
    Christison, J.
    Frater, A.
    Waller, J.
    BRITISH JOURNAL OF CANCER, 2011, 104 (06) : 915 - 920
  • [24] Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs
    Gupta, Sarah
    Palmer, Christina
    Bik, Elisabeth M.
    Cardenas, Juan P.
    Nunez, Harold
    Kraal, Laurens
    Bird, Sara W.
    Bowers, Jennie
    Smith, Alison
    Walton, Nathaniel A.
    Goddard, Audrey D.
    Almonacid, Daniel E.
    Zneimer, Susan
    Richman, Jessica
    Apte, Zachary S.
    FRONTIERS IN PUBLIC HEALTH, 2018, 6
  • [25] Results of a community-based cervical cancer screening pilot project using human papillomavirus self-sampling in Kampala, Uganda
    Ogilvie, Gina S.
    Mitchell, Sheona
    Sekikubo, Musa
    Biryabarema, Christine
    Byamugisha, Josaphat
    Jeronimo, Jose
    Miller, Dianne
    Steinberg, Malcolm
    Money, Deborah M.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2013, 122 (02) : 118 - 123
  • [26] Using community engagement to inform and implement a community-randomized controlled trial in the Anishinaabek cervical cancer screening study
    Wood, Brianne
    Burchell, Ann N.
    Escott, Nicholas
    Little, Julian
    Maar, Marion
    Ogilvie, Gina
    Severini, Alberto
    Bishop, Lisa
    Morrisseau, Kyla
    Zehbe, Ingeborg
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [27] Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer - Reply
    Runowicz, Carolyn D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (06): : 644 - 644
  • [28] Study Protocol: Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-Sampling in Cervical Cancer Screening (Vol 67, 1604284, 2022)
    Lefeuvre, Caroline
    De Pauw, Helene
    Le Duc Banaszuk, Anne-Sophie
    Pivert, Adeline
    Ducancelle, Alexandra
    Rexand-Galais, Franck
    Arbyn, Marc
    INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2024, 69
  • [29] Somali American Perspectives on Human Papillomavirus (HPV) Self-Sampling to address Cervical Cancer Screening Disparities
    Pratt, Rebekah
    Szpiro, Adam
    Fordyce, Kristi
    Lin, John
    Weiner, Bryan
    Ghebre, Rahel
    Ramer, Timothy J.
    Barsness, Christina Bliss
    Winer, Rachel
    Desai, Jay
    Yohe, Sophia
    Ibrahim, Anisa
    ANNALS OF FAMILY MEDICINE, 2024, 22
  • [30] Effectiveness and feasibility of self-sampling for human papillomavirus testing for internet-based cervical cancer screening
    Li, Jingran
    Wu, Ruifang
    Qu, Xinfeng
    Huang, Xia
    Li, Ling
    Lin, Zhixin
    Zhang, Zhijun
    Deng, Jihong
    Liu, Rong
    Zhao, Xiaofeng
    Zhang, Songling
    Lin, Bei
    An, Ruifang
    Zhao, Chao
    Li, Mingzhu
    Zhao, Yun
    Wei, Lihui
    FRONTIERS IN PUBLIC HEALTH, 2022, 10